Compliance Conference 2015: Prevention is better than cure Go back »
Click here to view pictures of this event.
-
Time2015-10-15 | 14:30 - 19:00
-
Venue:Grand Kempinski Hotel Shanghai
-
Address:
-
Fee:Members: 400 RMB |
Non Members: 600 RMB
We would love to hear your feedback, and it just takes a minute.
Compliance is becoming one of the main focuses of business worldwide. With the Foreign Corrupt Practices Act (FCPA) and the UK Anti-Bribery Act being applied to business outside the US and the UK and President Xi’s anti-corruption campaign becoming a feature of the business environment in China, the stakes are higher than ever for MNC’s doing business in China. The consequences of not being compliant can be far reaching and the solution is not merely to have the best compliance programme, it also has to work. How to monitor your compliance programme and make sure problems are prevented from arising is the key concern.
Our half-day conference Compliance: Prevention is better than cure will bring together experts who will share their expertise and experience, providing relevant updates and explaining the best ways for companies to ensure that their compliance programmes are up to scratch.
This event is sponsored by Ernst & Young - Fraud Investigation & Dispute Services
AGENDA
14:00 to 14:30 Registration
14:30 to 14:45 Welcome Remarks by Graham Wladimiroff, Chair of the Compliance and Business Ethics Working Group, European Chamber
14:45 to 15:20 "Fraud and Corruption-Driving Away Talent? - Key compliance trends and the importance of getting it right" by Emmanuel Vignal, Partner, Fraud Investigation & Dispute Services at EY
15:25 to 16:00 "Keeping clean - Prevention and Monitoring Tools for Mitigating Compliance Risks in China" by Philipp Senff, Head of Compliance Group and Legal Director, Pinsent Masons LLP
16:00 to 16:35 "Third Party Intermediary’s risks in China" by Clarissa Shen, Country Compliance Officer, Sanofi
16:35 to 16:40 On-stage interview with Sanofi by David Du, Vice-Chair of the Compliance and Business Ethics Working Group, European Chamber
16:40 to 17:00 Coffee Break
17:00 to 18:00 Panel discussion moderated by David Du and Edwin Li, Vice-Chair of the Compliance and Business Ethics Working Group, European Chamber
18:00 to 19:00 Cocktail Reception
Terms & Conditions:
Events have limited seating so to ensure your attendance we encourage advance online registration and payment for ALL events. We cannot guarantee entry to anyone not registered in advance.
Cancellation Policy:
If you cannot attend an event for which you have registered, please cancel your registration no later than one business day prior to the event. If you fail to notify us of your cancellation in a timely fashion, you will be charged for event costs.
To cancel you can: cancel online if you registered for the event through the website.
Downloads
Speakers
Mr. Emmanuel Vignal
Mr. Emmanuel Vignal
Emmanuel is the Greater China Leader of EY’s Fraud Investigation & Dispute Services (FIDS). He is also a certified member of the Association of Certified Fraud Examiners (ACFE) and leads the ACFE chapter in Shanghai. Emmanuel has 20 years of experience in fraud investigations, anti-bribery/anti-corruption reviews, transactions forensics and litigation support, including over 16 years in Hong Kong and Shanghai. He is routinely involved in risk assessments at the Chinese operations of MNCs and in FCPA/integrity due diligence. With a forensic accounting background, he has led numerous investigations in China in response to allegations of corrupt payments disguised as legitimate business expenses, payments through travel agents or consultants. Furthermore, Emmanuel has also worked on numerous dispute assignments and given evidence on accounting matters and valuation issues in arbitration proceedings in London, Hong Kong, Beijing and Tokyo.
Ms. Clarissa Shen Yanrong
Ms. Clarissa Shen Yanrong
Clarissa SHEN had been Sanofi China Head for Global Ethics and Business Integrity function since Feb. 2012. Her main responsibilities are to partner with Sanofi China Country Chair to ensure the affiliate’s business operation to the company’s highest ethical standards. Since Oct. 2020, Clarissa has taken up a new role as Head of EBI China Strategic Competence Development in ensuring that the E&BI department incorporates compliance risk areas across its disciplines and foster the competencies development of China team. Between 2017 and 2019, Clarissa has co-chaired the Compliance Working of RDPAC (An industry association, affiliated to CAEFI, consists of 42 Pharma MNCs), where she won the award of 2018 RDPAC Code & Ethics Ambassador and 2019 RDPAC Best Contributor. In 2020, Clarissa acted as the keynote speaker for Post Covid-19 Compliance Conference for Healthcare Industry in China (financially sponsored by the World Bank for a Siemen’s Global Compliance Program, centred at East China Normal University), on behalf of RDPAC and its member Sanofi.
In 2017, Clarissa co-authored an article of “An Overview of Compliance in China – the Pharma Sector”, which was published by the German HAUFE. The book is entitled as “Governance, Risk and Compliance Management in China”.
Clarissa has been a Board member for European Union Chamber of Commerce (EUCCC) Shanghai Chapter since Mar. 2016. During 2017 EU Delegation Tour to Brussels, Clarissa, in team with EUCCC China President and RDPAC Managing Director participated a high-level dialogue with EU DG SANTE Commissioner Vytenis Andriukaitis and his team, to have exchanged views on Rare Disease Reimbursement Policy and Business Ethic.
Apart from Sanofi, Clarissa has 20+ years’ business and people management experiences in terms of customer service/demand planning/business operation/credit and supply chain management/distributorship management with BMS, Eli Lilly and Ciba Specialty Chemicals.
Clarissa holds a bachelor’s degree from Shanghai University and an MBA degree from University of Canterbury, New Zealand. In year 2019, she was nominated as the first International Board member for Canterbury MBA association.
Mr. Philipp Senff
Mr. Philipp Senff
Philipp Senff, based in the firm's Shanghai office, is heading the compliance and risk management group. Philipp is recognized as leading compliance and risk management lawyer with over 10 years of China related legal work and business experience. Philipp is representing multinational companies on the development and enforcement of robust tools for the identification and mitigation of compliance risks in China, which include internal investigations, risk assessments, restructuring of transparent procurement and sales structures, strengthening corporate governance and crisis management. Before joining Pinsent Masons Philipp was for several years the Head of the Shanghai office of a UK law firm.